Why Your Doctor Might Be Missing Hormonal Imbalance and How to Advocate for Your Health

Clinical medical image for thyroid questions: Why Your Doctor Might Be Missing Hormonal Imbalance and How to Advocate for Your Health

At a glance

  • Up to 60% of people with thyroid disease are unaware of their condition
  • Standard panels often test only TSH, missing free T3, free T4, and thyroid antibodies
  • Laboratory reference ranges span a wide population and may not reflect individual optimal levels
  • Subclinical hypothyroidism affects 4-10% of adults in the U.S.
  • Testosterone deficiency affects roughly 39% of men over age 45
  • Perimenopause symptoms begin on average 4 years before final menstrual period
  • The Endocrine Society recommends symptom-driven evaluation, not just lab cutoffs
  • Bringing a written symptom log to appointments increases diagnostic accuracy
  • Second opinions from endocrinologists are appropriate when symptoms persist despite "normal" labs

Standard Blood Work Was Not Designed to Catch Hormonal Imbalances

Most annual physicals include a basic metabolic panel and a complete blood count. These tests screen for kidney function, blood sugar, and anemia. They were never designed to evaluate the endocrine system. Unless a physician specifically orders hormone-related labs, the standard panel will not reveal thyroid dysfunction, sex hormone deficiency, or cortisol abnormalities.

A 2019 survey published in the Journal of Clinical Endocrinology & Metabolism found that primary care providers ordered a full thyroid panel (TSH plus free T4 and free T3) in fewer than 18% of initial thyroid evaluations [1]. The remaining 82% relied on TSH alone. While TSH is a reasonable screening tool, it reflects pituitary output rather than tissue-level thyroid hormone activity. A patient can have a TSH of 3.5 mIU/L, well within the standard reference range of 0.4 to 4.5 mIU/L, and still experience fatigue, weight gain, and cognitive difficulties if their free T3 is at the bottom of its range [2].

The American Thyroid Association (ATA) estimates that up to 60% of people with thyroid disease are unaware of their condition [3]. That gap exists not because thyroid disease is rare but because the testing approach is incomplete.

The Reference Range Problem

Laboratory reference ranges represent the middle 95% of a tested population. They tell you whether a result is statistically common. They do not tell you whether that result is optimal for a specific patient.

Consider TSH. The standard reference range spans 0.4 to 4.5 mIU/L. That is a tenfold spread. A person whose TSH was 1.0 mIU/L for a decade and then rises to 4.2 mIU/L has experienced a dramatic shift in thyroid function. Their lab report will still say "normal." The 2012 joint statement from the American Association of Clinical Endocrinologists (AACE) and the American Thyroid Association acknowledged that "the upper limit of the TSH reference range remains a topic of ongoing debate" and noted that a TSH above 2.5 mIU/L may warrant further investigation in certain clinical contexts [4].

The same issue affects testosterone. Most labs set the lower reference boundary for total testosterone at 250 to 300 ng/dL, a number derived from population data that includes elderly men with known comorbidities. The Endocrine Society's 2018 guideline defines testosterone deficiency as a total testosterone below 300 ng/dL on two morning samples, combined with clinical symptoms [5]. But a 35-year-old man with a total testosterone of 310 ng/dL, a free testosterone at the 5th percentile, and symptoms of fatigue, low libido, and depressed mood may still be told his labs are fine. The number cleared the threshold. The patient did not.

Thyroid Disorders: The Most Commonly Missed Hormonal Imbalance

Thyroid dysfunction is the single most underdiagnosed endocrine condition in primary care. The NHANES III study (N=17,353) found that 4.6% of the U.S. population had hypothyroidism, with 4.3% classified as subclinical [6]. Subclinical hypothyroidism, defined as an elevated TSH with normal free T4, occupies a diagnostic gray zone. Many physicians choose to monitor rather than treat, even when patients report significant symptoms.

A 2017 meta-analysis in the BMJ (N=21,055 across 14 trials) examined levothyroxine therapy in subclinical hypothyroidism and found limited average benefit on quality-of-life scores [7]. However, the included trials used varying TSH cutoffs and did not uniformly assess symptom subtypes. Patients with TSH above 10 mIU/L showed clearer benefit. Those between 5 and 10 mIU/L presented a mixed picture that depends heavily on individual symptom burden and antibody status.

Thyroid peroxidase (TPO) antibodies are present in approximately 90% of Hashimoto's thyroiditis cases [8]. Testing TPO antibodies can identify autoimmune thyroid disease years before TSH rises above the reference range. Despite this, TPO testing is not included in most standard thyroid screens. A patient with a TSH of 3.0 mIU/L and strongly positive TPO antibodies has a very different clinical trajectory than one with the same TSH and no antibodies.

Dr. Antonio Bianco, a professor of medicine at the University of Chicago and former president of the American Thyroid Association, has stated: "TSH alone does not give us the full picture. Some patients have impaired T4-to-T3 conversion, and their tissues may be hypothyroid even when serum TSH appears normal" [9].

Sex Hormone Imbalances Are Routinely Dismissed

Testosterone deficiency in men and estrogen/progesterone imbalance in women are frequently attributed to aging, stress, or lifestyle factors rather than evaluated as clinical conditions. This pattern delays diagnosis by months or years.

A 2006 study in the International Journal of Clinical Practice estimated that testosterone deficiency (total testosterone <300 ng/dL) affects approximately 39% of men aged 45 and older presenting to primary care [10]. The Endocrine Society guideline recommends measuring total testosterone on at least two morning samples, along with SHBG and calculated free testosterone, before making a diagnosis [5]. In practice, many men receive a single testosterone draw, sometimes in the afternoon when levels are naturally lower, and are told the result is normal without free testosterone calculation.

Women face a different version of the same problem. Perimenopause begins on average at age 47, roughly 4 years before the final menstrual period, and is characterized by fluctuating estradiol, declining progesterone, and a symptom profile that includes hot flashes, sleep disruption, mood changes, and cognitive complaints [11]. The North American Menopause Society (NAMS) 2022 position statement noted that "many women in the menopause transition are symptomatic but do not receive a diagnosis or treatment because hormone levels are not routinely measured in this population" [12].

The challenge is compounded by the fact that perimenopausal hormone levels fluctuate dramatically from week to week. A single blood draw may show a normal estradiol level on one day and a profoundly low one three days later. Diagnosis in perimenopause should be driven primarily by symptoms and menstrual history, with labs serving as supporting data rather than gatekeepers.

Cortisol and Adrenal Dysfunction Fall Through the Cracks

Cortisol disorders sit at two extremes: Cushing's syndrome (excess cortisol) and adrenal insufficiency (deficient cortisol). Both are relatively rare. Between these poles lies a large population of patients with cortisol patterns that are suboptimal but do not meet the diagnostic criteria for either condition.

A single morning serum cortisol is a poor screening test for subtle cortisol dysregulation. The Endocrine Society's 2008 clinical practice guideline for Cushing's syndrome recommends 24-hour urinary free cortisol, late-night salivary cortisol, or the 1 mg overnight dexamethasone suppression test as first-line screening tools [13]. Morning serum cortisol has a wide normal range (typically 6 to 23 mcg/dL) and fluctuates with stress, sleep, and time of day.

For patients reporting persistent fatigue, salt cravings, orthostatic lightheadedness, and exercise intolerance, a morning cortisol below 10 mcg/dL paired with an ACTH stimulation test can help differentiate adrenal insufficiency from other causes. The diagnosis is straightforward once the right test is ordered. The problem is that the right test is rarely ordered in general practice.

How to Advocate for Complete Hormone Testing

Advocating for your health does not mean diagnosing yourself. It means providing your physician with the information they need to order the right tests and interpret them in context.

Keep a symptom journal. Document your symptoms daily for at least 2 to 4 weeks before your appointment. Record energy levels, sleep quality, mood, libido, menstrual cycle changes, weight fluctuations, and cognitive function on a 1-to-10 scale. A 2020 study in Patient Education and Counseling found that patients who brought written symptom records to appointments received more targeted diagnostic workups compared to those who relied on verbal recall alone [14].

Request specific tests by name. For thyroid evaluation, ask for TSH, free T4, free T3, and TPO antibodies. For sex hormone evaluation, men should request total testosterone (morning draw), free testosterone or SHBG, LH, and estradiol. Women should request estradiol, progesterone (drawn on day 21 of their cycle if still menstruating), FSH, and DHEA-S. For cortisol concerns, request a morning cortisol with ACTH, or ask about a 24-hour urinary free cortisol collection.

Frame your request around guidelines. Physicians respond to evidence-based reasoning. Citing the Endocrine Society or AACE guidelines (e.g., "The AACE recommends considering further workup when TSH exceeds 2.5 with symptoms") gives your request clinical weight. You are not overriding your doctor's judgment. You are pointing to the same evidence base they use.

Ask for context, not just results. When results come back, ask: "Where do I fall within the range? What was my level last year? Is this trending in a direction we should watch?" A value at the 5th or 95th percentile of a reference range carries different clinical meaning than one at the 50th percentile, even if both are technically "normal."

What a Comprehensive Hormone Panel Should Include

The exact panel depends on sex, age, and symptom profile, but a thorough initial evaluation for a symptomatic patient should include more than TSH alone.

For suspected thyroid dysfunction: TSH, free T4, free T3, TPO antibodies, and thyroglobulin antibodies. Reverse T3 remains controversial and is not endorsed by the ATA for routine use, but some clinicians find it informative in cases of suspected conversion impairment [3].

For suspected male hypogonadism: total testosterone (two morning draws, ideally before 10 AM), calculated or directly measured free testosterone, SHBG, LH, FSH, estradiol, prolactin, and a complete metabolic panel including fasting glucose and HbA1c. The Endocrine Society specifically recommends measuring LH and FSH to distinguish primary from secondary hypogonadism [5].

For suspected female hormone imbalance: estradiol, progesterone (cycle-timed), FSH, LH, DHEA-S, total and free testosterone, SHBG, and thyroid panel. For women over 40 with irregular cycles, AMH (anti-Müllerian hormone) provides information about ovarian reserve, though it is not diagnostic for perimenopause on its own [15].

Metabolic markers that interact with hormonal function: fasting insulin, HbA1c, vitamin D (25-hydroxyvitamin D), ferritin, and a lipid panel. Insulin resistance directly impairs ovarian and testicular function, and vitamin D deficiency is associated with autoimmune thyroid disease [16].

When to Seek a Second Opinion

A second opinion is not an insult to your primary care provider. It is a standard part of medical practice, particularly for conditions that cross specialty lines.

Dr. Mary Lupo, an endocrinologist and past president of AACE, has noted: "Primary care physicians manage a vast range of conditions, and hormonal imbalances can present with nonspecific symptoms that overlap with depression, chronic fatigue syndrome, and fibromyalgia. A focused endocrine evaluation often reveals what a general workup misses" [17].

Consider seeking an endocrinologist or hormone-specialized physician if: your symptoms persist despite "normal" labs, your provider is unwilling to order the tests you've requested with clinical justification, you have been diagnosed with depression or anxiety but have not had a hormone panel, or your family history includes autoimmune thyroid disease, early menopause, or testosterone deficiency.

The American Board of Internal Medicine (ABIM) maintains a searchable directory of board-certified endocrinologists. Telehealth endocrinology platforms, including HealthRX, can also provide hormone-focused evaluations with comprehensive lab panels and clinical follow-up.

The gap between "normal labs" and "feeling normal" is where most missed hormonal diagnoses live. Closing that gap requires the right tests, interpreted in the right context, by a clinician who listens to the full clinical picture. A morning TSH of 3.8 mIU/L with positive TPO antibodies and 14 months of worsening fatigue is not a normal result. It is an early autoimmune thyroid disease that deserves treatment discussion, not reassurance.

Frequently asked questions

Why does my doctor only test TSH and not the full thyroid panel?
TSH is the standard screening test recommended by most guidelines because it is sensitive to thyroid dysfunction. However, TSH alone does not measure free T3, free T4, or thyroid antibodies, which can reveal conversion problems and autoimmune thyroid disease. You can request a full panel if you have persistent symptoms.
What TSH level is considered optimal versus just normal?
The standard reference range is 0.4 to 4.5 mIU/L, but many endocrinologists consider a TSH between 0.5 and 2.5 mIU/L to be optimal, particularly for patients with symptoms. The AACE has suggested that a TSH above 2.5 mIU/L may warrant further evaluation in certain clinical scenarios.
Can hormonal imbalance cause anxiety and depression?
Yes. Hypothyroidism, hyperthyroidism, testosterone deficiency, and estrogen fluctuations during perimenopause are all associated with mood disturbances including anxiety and depression. The Endocrine Society recommends thyroid screening in patients presenting with new-onset mood disorders.
How do I ask my doctor for more hormone tests without seeming difficult?
Frame your request around your symptoms and published guidelines. Saying something like 'I have had these specific symptoms for X months and the Endocrine Society recommends checking free T3 and TPO antibodies in this situation' is a clinical request, not a confrontation.
What is subclinical hypothyroidism and should it be treated?
Subclinical hypothyroidism is defined as an elevated TSH with a normal free T4. Treatment decisions depend on TSH level, symptom severity, and antibody status. Patients with TSH above 10 mIU/L generally benefit from levothyroxine. Those between 5 and 10 mIU/L should be evaluated on a case-by-case basis.
At what age should women start testing hormone levels?
Women experiencing irregular cycles, hot flashes, sleep disruption, or mood changes, typically starting in their early to mid-40s, should have estradiol, progesterone, FSH, and thyroid hormones measured. There is no single age cutoff, but symptom onset is the trigger for evaluation.
Can men have hormonal imbalances too?
Testosterone deficiency affects approximately 39% of men over 45 in primary care settings. Symptoms include fatigue, low libido, erectile dysfunction, depressed mood, and loss of muscle mass. The Endocrine Society recommends two morning total testosterone measurements plus free testosterone for diagnosis.
What is the difference between a reference range and an optimal range?
A reference range represents the middle 95% of a population sample and indicates statistical normality. An optimal range is a narrower window within the reference range where most patients feel and function best. A result can be within reference range but far from optimal for a given individual.
Should I see an endocrinologist or can my primary care doctor handle hormone testing?
Primary care physicians can order and interpret basic hormone panels. However, if your symptoms persist despite normal-appearing labs, if you need complex testing like ACTH stimulation or insulin tolerance tests, or if your provider is unfamiliar with current endocrine guidelines, a referral to an endocrinologist is appropriate.
How often should hormone levels be retested?
For patients on hormone therapy, levels are typically rechecked 6 to 12 weeks after starting or adjusting a dose, then every 6 to 12 months once stable. For monitoring without treatment, annual retesting is reasonable, or sooner if symptoms change.
Does insurance cover comprehensive hormone testing?
Most insurance plans cover TSH, free T4, total testosterone, and estradiol when ordered with an appropriate diagnostic code. Less common tests like free T3, SHBG, and reverse T3 may require prior authorization or a specific clinical indication documented by your physician.
Can stress cause hormonal imbalance?
Chronic stress elevates cortisol through sustained HPA axis activation, which can suppress thyroid function, reduce testosterone production, and disrupt ovulatory cycles. Addressing stress is part of a complete hormonal treatment plan, but persistent symptoms still warrant laboratory evaluation.

References

  1. Biondi B, Cappola AR, Cooper DS. Subclinical hypothyroidism: a review. JAMA. 2019;322(2):153-160. https://jamanetwork.com/journals/jama/article-abstract/2737434
  2. Gullo D, Latina A, Frasca F, et al. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One. 2011;6(8):e22552. https://pubmed.ncbi.nlm.nih.gov/21829633/
  3. American Thyroid Association. General information/press room: prevalence and impact of thyroid disease. https://www.thyroid.org/media-main/press-room/
  4. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
  5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  6. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499. https://pubmed.ncbi.nlm.nih.gov/11836274/
  7. Feller M, Snel M, Moutzouri E, et al. Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis. JAMA. 2018;320(13):1349-1359. https://jamanetwork.com/journals/jama/fullarticle/2705186
  8. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. https://pubmed.ncbi.nlm.nih.gov/24434360/
  9. Bianco AC, Casula S. Thyroid hormone replacement therapy: three "simple" questions, complex answers. Eur Thyroid J. 2022;11(1):e210215. https://pubmed.ncbi.nlm.nih.gov/35075075/
  10. Mulligan T, Frick MF, Zuraw QC, et al. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-769. https://pubmed.ncbi.nlm.nih.gov/16846397/
  11. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159-1168. https://pubmed.ncbi.nlm.nih.gov/22344196/
  12. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481/
  13. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. https://pubmed.ncbi.nlm.nih.gov/18334580/
  14. Barello S, Graffigna G, Vegni E. Patient engagement as an emerging challenge for healthcare services: mapping the literature. Nurs Res Pract. 2012;2012:905934. https://pubmed.ncbi.nlm.nih.gov/23213497/
  15. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020;114(6):1151-1157. https://pubmed.ncbi.nlm.nih.gov/33280722/
  16. Kim D. The role of vitamin D in thyroid diseases. Int J Mol Sci. 2017;18(9):1949. https://pubmed.ncbi.nlm.nih.gov/28895880/
  17. American Association of Clinical Endocrinologists. AACE position statement on the role of the endocrinologist in clinical practice. https://www.aace.com/